BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31050187)

  • 21. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes.
    Arias-Salgado EG; Galvez E; Planas-Cerezales L; Pintado-Berninches L; Vallespin E; Martinez P; Carrillo J; Iarriccio L; Ruiz-Llobet A; Catalá A; Badell-Serra I; Gonzalez-Granado LI; Martín-Nalda A; Martínez-Gallo M; Galera-Miñarro A; Rodríguez-Vigil C; Bastos-Oreiro M; Perez de Nanclares G; Leiro-Fernández V; Uria ML; Diaz-Heredia C; Valenzuela C; Martín S; López-Muñiz B; Lapunzina P; Sevilla J; Molina-Molina M; Perona R; Sastre L
    Orphanet J Rare Dis; 2019 Apr; 14(1):82. PubMed ID: 30995915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
    Ricca I; Compagno M; Ladetto M; Rocci A; Dell'Aquila M; Omedè P; De Marco F; D'Antico S; Caracciolo D; Ferrero D; Carlo-Stella C; Tarella C
    Leukemia; 2005 Apr; 19(4):644-51. PubMed ID: 15716989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
    Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
    Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
    J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of telomere length testing in a hospital-based setting.
    Alder JK; Hanumanthu VS; Strong MA; DeZern AE; Stanley SE; Takemoto CM; Danilova L; Applegate CD; Bolton SG; Mohr DW; Brodsky RA; Casella JF; Greider CW; Jackson JB; Armanios M
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2358-E2365. PubMed ID: 29463756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
    Kim HS; Lee HS; Nam KH; Choi J; Kim WH
    Anticancer Res; 2015 Jun; 35(6):3501-10. PubMed ID: 26026117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor.
    Merdin A; Çakar MK; Dal MS; Mert D; Yıldız J; Başçı S; Bakırtaş M; Darçın T; Şahin D; Ulu BU; Yiğenoğlu TN; Batgi H; Tetik A; İskender D; Altuntaş F
    J Oncol Pharm Pract; 2020 Jun; 26(4):929-932. PubMed ID: 31822199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomere length in interstitial lung diseases.
    Snetselaar R; van Moorsel CHM; Kazemier KM; van der Vis JJ; Zanen P; van Oosterhout MFM; Grutters JC
    Chest; 2015 Oct; 148(4):1011-1018. PubMed ID: 25973743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dicarbamine as a hemoprotective agent in patients with hemoblastoses treated with chemotherapy].
    Ivanova OV
    Vopr Onkol; 2012; 58(3):416-9. PubMed ID: 22888661
    [No Abstract]   [Full Text] [Related]  

  • 30. Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome.
    Du HY; Idol R; Robledo S; Ivanovich J; An P; Londono-Vallejo A; Wilson DB; Mason PJ; Bessler M
    Aging Cell; 2007 Oct; 6(5):689-97. PubMed ID: 17875000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).
    Pavone V; Mele A; Carlino D; Specchia G; Gaudio F; Perrone T; Mazza P; Palazzo G; Guarini A; Loseto G; Eleonora P; Cascavilla N; Scalzulli P; Melpignano A; Quintana G; Di Renzo N; Tarantini G; Capalbo S
    Ann Hematol; 2018 Oct; 97(10):1817-1824. PubMed ID: 30054707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
    J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.
    Kikuchi M; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kako S; Kanda J; Nishida J; Sekiguchi N; Noto S; Kida M; Hangaishi A; Usuki K; Kanda Y
    J Chemother; 2015 Feb; 27(2):99-105. PubMed ID: 25314911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
    Kubuki Y; Suzuki M; Sasaki H; Toyama T; Yamashita K; Maeda K; Ido A; Matsuoka H; Okayama A; Nakanishi T; Tsubouchi H
    Leuk Lymphoma; 2005 Mar; 46(3):393-9. PubMed ID: 15621829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The short and long telomere syndromes: paired paradigms for molecular medicine.
    Stanley SE; Armanios M
    Curr Opin Genet Dev; 2015 Aug; 33():1-9. PubMed ID: 26232116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic predisposition to advanced biological ageing increases risk for childhood-onset recurrent major depressive disorder in a large UK sample.
    Michalek JE; Kepa A; Vincent J; Frissa S; Goodwin L; Hotopf M; Hatch SL; Breen G; Powell TR
    J Affect Disord; 2017 Apr; 213():207-213. PubMed ID: 28233563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
    Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
    Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
    Both A; Krauter J; Damm F; Thol F; Göhring G; Heuser M; Ottmann O; Lübbert M; Wattad M; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Brugger W; Schlegelberger B; Heil G; Ganser A; Wagner K
    Ann Hematol; 2017 Jun; 96(6):895-904. PubMed ID: 28331964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced telomere length in colorectal carcinomas.
    Feng TB; Cai LM; Qian KQ; Qi CJ
    Asian Pac J Cancer Prev; 2012; 13(2):443-6. PubMed ID: 22524803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere shortening in blood leukocytes of patients with posttraumatic stress disorder.
    Avetyan D; Zakharyan R; Petrek M; Arakelyan A
    J Psychiatr Res; 2019 Apr; 111():83-88. PubMed ID: 30685566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.